Lundbeck and IBM Watson Health form collaboration on technology for developing innovative medicine
H. Lundbeck A/S (Lundbeck) is collaborating with IBM’s Watson Health to accelerate the development of innovative medicines to treat psychiatric and neurological disorders. The collaboration will combine Lundbeck’s expertise in the treatment of psychiatric and neurological disorders with IBM’s cognitive and knowledge-based analytics to foster the discovery and development of new innovative treatments of disorders such as schizophrenia and Parkinson’s disease.“We strive to develop treatments that affect the underlying biological mechanisms of psychiatric and neurological disorders rather than